We are proud to announce the launch of AI-QUAL™, an innovative new feature in our flagship QP-Prostate platform, designed to automate prostate MR image quality assessment using PI-QUAL v2 guidelines. Why is this a game changer? 🔹 Automated quality scoring to avoid manual checks 🔹 Standardized reporting for consistent image quality assessment, based on PI-QUAL v2 guidelines 🔹 Artifact detection to flag distortions such as rectal gas and metallic artifacts 🔹 Diagnostic confidence to empower radiologists with highest quality images 🔹 Seamless workflow integration With AI-QUAL, we're taking a giant leap forward in standardizing prostate MRI and support diagnostic accuracy. https://bit.ly/3Ieh04g #MedicalImaging #AIinHealthcare #ProstateCancer #DigitalHealth #PIQUAL #PIRADS #AIQUAL
Join us tomorrow for the second volume of our clinical case series: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2 | 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐞𝐧𝐝𝐨𝐫𝐬𝐞𝐝 𝐛𝐲 𝐒𝐄𝐑𝐀𝐌 This webinar offers a unique opportunity to explore how artificial intelligence is advancing the diagnosis of #ProstateCancer through real-world clinical cases. Featuring expert insights from: • Dr. Milagros Otero-García, MD • Dr. Fernando Losada, MD 🗓️ Date: June 26 🕒 Time: 19:00 CEST / 14:00 GMT-3 📢 Language: Spanish 👉 Register now: https://bit.ly/4jZSIsk #Radiology #HealthcareInnovation #AI #MedicalImagin #QPProstate #webinar
🧠 Millions of people face every day a disease that, to this day, has no cure. Alzheimer's kills more people than breast and prostate cancer combined, and a new case of dementia is diagnosed every 3.2 seconds. It is time to talk, to prevent and to support research. #AlzheimersAndBrainAwarenessMonth #AlzheimersAwareness #BrainHealth #BrainMonth #Alzheimers #DementiaAwareness
📍 The #FLUTE consortium meeting is happening today in Barcelona, the goal: to advance the future of AI-powered #ProstateCancer imaging. Some of the main topics we are working on together: 🔹 Analyzing bpMRI and mpMRI scans from IRST, VHIR and CHUL using QP-Prostate, including lesion and gland segmentation. 🔹 Validation of synthetic MRI images created by UPC using QP-Prostate and radiomics. 🔹 Training radiologists to edit lesions with QP-Care. 🔹 Supporting Gradiant in the development of predictive models, a central goal of the project. Exciting progress and strong alignment between teams, looking forward to what's next! #AIinHealthcare #Radiology #MedicalImaging #Radiomics
🇭🇷 Promising updates from the RadioVal Consortium Meeting in Zagreb! We are integrating AI into the RadioVal clinical decision support system (powered by QP-Insights) with: ▪️ Automatic lesion segmentation ▪️ 3-year pCR and survival prediction ▪️ Continuous monitoring of model drift Quibim also leads the sustainability and exploitation strategy, which includes market analysis and assessment of the technology landscape to ensure long-term impact in #BreastCancer care. #AIinHealthcare #DigitalHealth #MedicalImaging
The 13th #ESUR prostate MRI course is being held today in Cambridge. Being close to clinical reality - and to the professionals who apply advanced imaging in practice - is essential to innovate with purpose. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer care. #ProstateMRI #Oncology #MedicalImaging #Radiology #HealthTech #MedicalInnovation
Advanced prostate cancer survival has tripled in the last 15 years, according to Sociedad Española de Oncología Médica (SEOM), thanks to: ➡️ Next-gen hormonal therapies ➡️ Novel chemotherapies and radioisotopes ➡️ PARP inhibitors for patients with BRCA1/2 mutations These advances are extending survival and improving quality of life through biomarker-guided, personalized strategies. At Quibim, we support this progress with QP-Prostate®, our AI-powered solution for earlier, more precise detection of aggressive prostate cancer. By standardizing interpretation and identifying lesions automatically, QP-Prostate® enables faster, more confident decisions in precision oncology. Innovation in diagnostics is saving lives. Let’s keep pushing forward. #ProstateCancer #PrecisionMedicine #AIinRadiology #MedicalImaging #QPProstate #OncologyInnovation #SEOM2025 #ImagingBiomarkers
📅 On #WorldProstateCancerDay, we join the global effort to raise awareness of one of the most prevalent cancers among men. 🔍 Early detection and accurate diagnosis are critical to improving patient outcomes. To celebrate the occasion, we invite you to participate in an exclusive SERAM - Sociedad Española de Radiología Médica-endorsed webinar featuring Dr. Milagros Otero-García and Dr. Fernando Losada on June 26 at 7PM CEST (Spain) / 2PM GMT -3 (LATAM). Let’s embrace this as an opportunity to improve clinical practice with the latest innovations in #ProstateCancer imaging and care. 👉 Register now: https://bit.ly/4jZSIsk #Radiology #MedicalImaging #HealthInnovation
Today, our Director of Business Development – EMEA, LATAM, and APAC, Javier Pizcueta Pastor, participated in the I Interautonomic Meeting on Digital Transformation in the Healthcare Sector, held in Madrid. This exclusive gathering brought together regional health leaders, innovation decision-makers, and key players from the tech ecosystem to: 🤝 Exchange strategic insights across Spain 🔍 Identify shared challenges in digital transformation 💡 Promote innovative, scalable solutions for both regional and national implementation We're proud to contribute to shaping a more connected, digital, and forward-looking healthcare system. #DigitalHealth #HealthInnovation #HealthTechnology #ConnectedCare
In this video, the IAF (Instituto Alexander Fleming) shares the real-world impact of implementing QP-Prostate®—a powerful example of how AI can enhance clinical workflows and improve outcomes in prostate cancer care. Their experience underscores the value of integrating the right tools to accelerate progress in precision medicine. A heartfelt thank you to the entire IAF team for their trust and collaboration. ➡️ Watch the full story: https://lnkd.in/dDQ8zg4X #ProstateCancer #PrecisionMedicine #DigitalHealth #AIinHealthcare #HealthInnovation
